Reply to J.A. Talcott
J Clin Oncol
.
2018 Sep 4:JCO2018793141.
doi: 10.1200/JCO.2018.79.3141.
Online ahead of print.
Authors
Randy A Taplitz
1
,
Erin B Kennedy
1
,
Christopher R Flowers
1
Affiliation
1
Randy A. Taplitz, UC San Diego Health, La Jolla, CA; Erin B. Kennedy, American Society of Clinical Oncology, Alexandria, VA; and Christopher R. Flowers, Emory University, Atlanta, GA.
PMID:
30179568
DOI:
10.1200/JCO.2018.79.3141
No abstract available